| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 80 | 2024 | 345 | 15.600 |
Why?
|
| Calcium Oxalate | 55 | 2024 | 188 | 8.860 |
Why?
|
| Calcium Phosphates | 18 | 2024 | 84 | 3.470 |
Why?
|
| Hypercalciuria | 13 | 2023 | 47 | 3.380 |
Why?
|
| Calcium | 26 | 2023 | 1205 | 3.100 |
Why?
|
| Kidney Medulla | 20 | 2024 | 79 | 2.500 |
Why?
|
| Kidney | 26 | 2024 | 1135 | 1.790 |
Why?
|
| Kidney Tubules | 9 | 2020 | 91 | 1.760 |
Why?
|
| Kidney Tubules, Proximal | 5 | 2019 | 60 | 1.530 |
Why?
|
| Nephrolithiasis | 5 | 2015 | 25 | 1.500 |
Why?
|
| Acid-Base Equilibrium | 3 | 2021 | 35 | 1.330 |
Why?
|
| Urinary Calculi | 11 | 2009 | 46 | 1.260 |
Why?
|
| Hyperoxaluria | 8 | 2023 | 26 | 1.220 |
Why?
|
| Oxalates | 10 | 2023 | 49 | 1.160 |
Why?
|
| Urine | 10 | 2021 | 96 | 1.120 |
Why?
|
| Renal Reabsorption | 2 | 2018 | 7 | 1.020 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2022 | 258 | 0.980 |
Why?
|
| Apatites | 10 | 2020 | 19 | 0.930 |
Why?
|
| Loop of Henle | 4 | 2018 | 11 | 0.890 |
Why?
|
| Postprandial Period | 5 | 2017 | 48 | 0.880 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2023 | 14 | 0.810 |
Why?
|
| Humans | 105 | 2024 | 95992 | 0.810 |
Why?
|
| Parathyroid Hormone | 6 | 2023 | 228 | 0.780 |
Why?
|
| Hydrogen-Ion Concentration | 12 | 2020 | 509 | 0.780 |
Why?
|
| Crystallization | 20 | 2019 | 216 | 0.750 |
Why?
|
| Kidney Tubules, Collecting | 6 | 2024 | 25 | 0.720 |
Why?
|
| Sialoglycoproteins | 7 | 2005 | 31 | 0.720 |
Why?
|
| Biomarkers | 8 | 2020 | 1931 | 0.690 |
Why?
|
| Lithotripsy | 5 | 2016 | 45 | 0.640 |
Why?
|
| Male | 60 | 2021 | 45792 | 0.640 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2018 | 78 | 0.630 |
Why?
|
| Acid-Base Imbalance | 1 | 2019 | 4 | 0.630 |
Why?
|
| Gastric Bypass | 1 | 2021 | 114 | 0.620 |
Why?
|
| Creatinine | 8 | 2021 | 299 | 0.610 |
Why?
|
| Basement Membrane | 2 | 2018 | 57 | 0.610 |
Why?
|
| Middle Aged | 45 | 2021 | 28299 | 0.610 |
Why?
|
| Female | 57 | 2021 | 49980 | 0.590 |
Why?
|
| Phosphoproteins | 3 | 2018 | 263 | 0.590 |
Why?
|
| Phosphates | 6 | 2024 | 167 | 0.580 |
Why?
|
| Vitamin D Deficiency | 2 | 2022 | 107 | 0.580 |
Why?
|
| Hyperparathyroidism, Secondary | 3 | 2015 | 71 | 0.570 |
Why?
|
| Hyperparathyroidism, Primary | 3 | 2010 | 45 | 0.560 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2018 | 13 | 0.560 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 7 | 0.560 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2018 | 33 | 0.560 |
Why?
|
| PDZ Domains | 1 | 2018 | 16 | 0.560 |
Why?
|
| Organic Anion Transporters | 1 | 2018 | 26 | 0.560 |
Why?
|
| Kidney Cortex | 3 | 2010 | 32 | 0.560 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 207 | 0.550 |
Why?
|
| Sex Factors | 6 | 2021 | 1130 | 0.520 |
Why?
|
| Vitamin D | 4 | 2022 | 273 | 0.520 |
Why?
|
| Ureteroscopy | 5 | 2022 | 38 | 0.520 |
Why?
|
| Uric Acid | 7 | 2020 | 137 | 0.520 |
Why?
|
| Adult | 40 | 2021 | 28636 | 0.510 |
Why?
|
| Dietary Supplements | 2 | 2015 | 133 | 0.510 |
Why?
|
| Renal Elimination | 2 | 2020 | 8 | 0.490 |
Why?
|
| Cystine | 2 | 2006 | 18 | 0.490 |
Why?
|
| Diuretics | 2 | 2013 | 77 | 0.470 |
Why?
|
| Kidney Tubules, Distal | 1 | 2015 | 19 | 0.450 |
Why?
|
| Calcium Compounds | 1 | 2014 | 2 | 0.440 |
Why?
|
| Obesity | 4 | 2020 | 1029 | 0.420 |
Why?
|
| X-Ray Microtomography | 6 | 2022 | 101 | 0.420 |
Why?
|
| Diet | 7 | 2019 | 460 | 0.410 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.410 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 75 | 0.400 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2013 | 9 | 0.390 |
Why?
|
| Risk Factors | 11 | 2021 | 5992 | 0.390 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 123 | 0.380 |
Why?
|
| Magnesium | 4 | 2023 | 178 | 0.380 |
Why?
|
| Biopsy | 9 | 2020 | 1210 | 0.370 |
Why?
|
| Kidney Diseases | 6 | 2014 | 323 | 0.370 |
Why?
|
| Jejunoileal Bypass | 2 | 2008 | 6 | 0.340 |
Why?
|
| Citric Acid | 3 | 2021 | 48 | 0.340 |
Why?
|
| Uromodulin | 4 | 2023 | 15 | 0.330 |
Why?
|
| Nephrostomy, Percutaneous | 5 | 2015 | 30 | 0.330 |
Why?
|
| Ileostomy | 2 | 2010 | 29 | 0.320 |
Why?
|
| Bicarbonates | 3 | 2021 | 58 | 0.320 |
Why?
|
| Glycoproteins | 4 | 1994 | 231 | 0.320 |
Why?
|
| Kidney Failure, Chronic | 4 | 2007 | 432 | 0.320 |
Why?
|
| Cystinuria | 2 | 2006 | 13 | 0.310 |
Why?
|
| Glomerular Filtration Rate | 5 | 2019 | 281 | 0.300 |
Why?
|
| Calcium, Dietary | 3 | 2023 | 68 | 0.300 |
Why?
|
| Aged | 23 | 2020 | 20927 | 0.290 |
Why?
|
| Nephrons | 1 | 2008 | 17 | 0.290 |
Why?
|
| Intestine, Small | 3 | 2010 | 310 | 0.290 |
Why?
|
| Hyaluronic Acid | 2 | 2008 | 53 | 0.290 |
Why?
|
| Renal Insufficiency | 2 | 2023 | 99 | 0.290 |
Why?
|
| Hypercalcemia | 1 | 2008 | 61 | 0.280 |
Why?
|
| Osteopontin | 9 | 2010 | 48 | 0.270 |
Why?
|
| Sodium | 4 | 2022 | 340 | 0.270 |
Why?
|
| Fasting | 3 | 2015 | 165 | 0.270 |
Why?
|
| Time Factors | 6 | 2017 | 5593 | 0.260 |
Why?
|
| Aging | 3 | 2021 | 766 | 0.260 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2007 | 11 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 5 | 2015 | 1096 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1962 | 0.250 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2014 | 138 | 0.230 |
Why?
|
| Thiazides | 3 | 2022 | 16 | 0.230 |
Why?
|
| Phosphorus | 3 | 2015 | 119 | 0.230 |
Why?
|
| Nephrectomy | 2 | 2006 | 297 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2010 | 2534 | 0.220 |
Why?
|
| Citrates | 2 | 2017 | 28 | 0.220 |
Why?
|
| Endoscopy | 4 | 2016 | 374 | 0.210 |
Why?
|
| Young Adult | 7 | 2019 | 7034 | 0.210 |
Why?
|
| Sulfates | 2 | 2021 | 59 | 0.210 |
Why?
|
| Sodium, Dietary | 1 | 2022 | 9 | 0.190 |
Why?
|
| Metabolomics | 1 | 2023 | 98 | 0.190 |
Why?
|
| Blood Pressure | 3 | 2015 | 926 | 0.180 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 116 | 0.170 |
Why?
|
| Rats | 6 | 2010 | 4155 | 0.170 |
Why?
|
| Water | 1 | 2023 | 307 | 0.170 |
Why?
|
| Secondary Prevention | 2 | 2013 | 180 | 0.170 |
Why?
|
| Nephrocalcinosis | 2 | 2015 | 9 | 0.170 |
Why?
|
| Animals | 15 | 2015 | 28901 | 0.170 |
Why?
|
| Urinalysis | 1 | 2021 | 34 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2018 | 3115 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2021 | 98 | 0.170 |
Why?
|
| Glucose | 1 | 2023 | 702 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2023 | 682 | 0.160 |
Why?
|
| Optical Imaging | 1 | 2020 | 51 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2021 | 318 | 0.160 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2011 | 38 | 0.160 |
Why?
|
| Gastrointestinal Absorption | 1 | 2019 | 4 | 0.160 |
Why?
|
| Ammonium Compounds | 1 | 2019 | 10 | 0.160 |
Why?
|
| Adolescent | 8 | 2019 | 9878 | 0.160 |
Why?
|
| Potassium | 3 | 2019 | 271 | 0.160 |
Why?
|
| Nephrolithotomy, Percutaneous | 4 | 2020 | 8 | 0.160 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 213 | 0.150 |
Why?
|
| Hypertension | 1 | 2005 | 775 | 0.150 |
Why?
|
| Lithium | 2 | 2010 | 62 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 2 | 2020 | 70 | 0.150 |
Why?
|
| Durapatite | 2 | 2014 | 36 | 0.150 |
Why?
|
| Urodynamics | 2 | 2020 | 130 | 0.150 |
Why?
|
| Aquaporin 1 | 1 | 2018 | 4 | 0.140 |
Why?
|
| Linear Models | 2 | 2021 | 438 | 0.140 |
Why?
|
| Chloride Channels | 1 | 2018 | 43 | 0.140 |
Why?
|
| Models, Biological | 2 | 2015 | 1810 | 0.140 |
Why?
|
| Phenotype | 1 | 2024 | 2575 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2020 | 221 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 157 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 1880 | 0.120 |
Why?
|
| Peptides | 2 | 2000 | 671 | 0.120 |
Why?
|
| Incidence | 1 | 2020 | 1723 | 0.120 |
Why?
|
| Calcinosis | 2 | 2014 | 232 | 0.120 |
Why?
|
| Crohn Disease | 1 | 2002 | 809 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2002 | 800 | 0.120 |
Why?
|
| Medullary Sponge Kidney | 1 | 2015 | 6 | 0.110 |
Why?
|
| Ammonium Chloride | 1 | 2015 | 22 | 0.110 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 50 | 0.110 |
Why?
|
| United States | 5 | 2015 | 7785 | 0.110 |
Why?
|
| Nephrology | 1 | 2015 | 46 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2015 | 50 | 0.110 |
Why?
|
| Kidney Transplantation | 2 | 2009 | 882 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 74 | 0.110 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 123 | 0.110 |
Why?
|
| Hyperphosphatemia | 1 | 2014 | 25 | 0.100 |
Why?
|
| Carbon-Carbon Ligases | 1 | 1993 | 2 | 0.100 |
Why?
|
| Mucoproteins | 2 | 1995 | 14 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2015 | 245 | 0.100 |
Why?
|
| Chlorthalidone | 1 | 2013 | 18 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 186 | 0.100 |
Why?
|
| Serum Albumin | 2 | 1995 | 127 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2015 | 277 | 0.100 |
Why?
|
| Warfarin | 1 | 1993 | 107 | 0.100 |
Why?
|
| Cystatin C | 2 | 2010 | 29 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2015 | 391 | 0.090 |
Why?
|
| Diet, Protein-Restricted | 1 | 2011 | 3 | 0.090 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2011 | 6 | 0.090 |
Why?
|
| Prognosis | 3 | 2015 | 3993 | 0.090 |
Why?
|
| Observer Variation | 3 | 2019 | 626 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2011 | 67 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2019 | 816 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2022 | 9228 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1966 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2777 | 0.080 |
Why?
|
| Allopurinol | 1 | 2010 | 77 | 0.080 |
Why?
|
| Anions | 2 | 2021 | 31 | 0.080 |
Why?
|
| Recurrence | 2 | 2010 | 1231 | 0.080 |
Why?
|
| Renal Dialysis | 3 | 2007 | 364 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2007 | 488 | 0.070 |
Why?
|
| Potassium Citrate | 1 | 2008 | 2 | 0.070 |
Why?
|
| Pregnancy Proteins | 1 | 1988 | 37 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 7224 | 0.070 |
Why?
|
| Hyperparathyroidism | 1 | 2008 | 65 | 0.070 |
Why?
|
| Microscopy, Polarization | 1 | 2008 | 13 | 0.070 |
Why?
|
| Insulin | 1 | 2013 | 1191 | 0.070 |
Why?
|
| Donor Selection | 1 | 2009 | 81 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 478 | 0.070 |
Why?
|
| Alpha-Globulins | 1 | 2007 | 11 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 1995 | 2928 | 0.070 |
Why?
|
| Health Surveys | 2 | 2005 | 245 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2008 | 126 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1166 | 0.070 |
Why?
|
| Iothalamic Acid | 1 | 2007 | 9 | 0.060 |
Why?
|
| Calcitriol | 1 | 2008 | 173 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 299 | 0.060 |
Why?
|
| Dietary Proteins | 1 | 2007 | 31 | 0.060 |
Why?
|
| Microvilli | 1 | 2006 | 44 | 0.060 |
Why?
|
| Infant | 1 | 2013 | 3359 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2885 | 0.060 |
Why?
|
| Tiopronin | 1 | 2006 | 6 | 0.060 |
Why?
|
| Algorithms | 1 | 2015 | 2018 | 0.060 |
Why?
|
| Drinking | 1 | 2006 | 35 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 125 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2013 | 3969 | 0.060 |
Why?
|
| Acute Disease | 1 | 2008 | 859 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 341 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2006 | 41 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2006 | 68 | 0.060 |
Why?
|
| Struvite | 1 | 2005 | 7 | 0.060 |
Why?
|
| Cell Polarity | 1 | 2006 | 119 | 0.060 |
Why?
|
| Magnesium Compounds | 1 | 2005 | 7 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2005 | 29 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 1267 | 0.060 |
Why?
|
| Systole | 1 | 2005 | 118 | 0.060 |
Why?
|
| Child | 3 | 2019 | 7621 | 0.060 |
Why?
|
| Diastole | 1 | 2005 | 147 | 0.060 |
Why?
|
| Kidney Pelvis | 1 | 2005 | 52 | 0.060 |
Why?
|
| Radiography | 1 | 2007 | 823 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 97 | 0.050 |
Why?
|
| Parathyroid Neoplasms | 1 | 2004 | 60 | 0.050 |
Why?
|
| Risk | 1 | 2005 | 666 | 0.050 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2009 | 2860 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2005 | 209 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1827 | 0.050 |
Why?
|
| Logistic Models | 1 | 2007 | 1273 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2023 | 84 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2008 | 519 | 0.050 |
Why?
|
| Alkalies | 1 | 2022 | 8 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 1355 | 0.050 |
Why?
|
| Solubility | 1 | 2002 | 190 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 86 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2020 | 2498 | 0.040 |
Why?
|
| Comorbidity | 1 | 2005 | 1017 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2003 | 340 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 179 | 0.040 |
Why?
|
| Smoking | 1 | 2005 | 651 | 0.040 |
Why?
|
| Proteins | 1 | 2006 | 816 | 0.040 |
Why?
|
| Carcinoma | 1 | 2004 | 444 | 0.040 |
Why?
|
| Microtomy | 1 | 2021 | 10 | 0.040 |
Why?
|
| Laser Capture Microdissection | 1 | 2021 | 20 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2020 | 29 | 0.040 |
Why?
|
| Polyglutamic Acid | 1 | 2000 | 15 | 0.040 |
Why?
|
| Mice | 5 | 2010 | 12525 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1982 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 255 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2003 | 1176 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2020 | 115 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2020 | 286 | 0.040 |
Why?
|
| Lipocalin-2 | 2 | 2010 | 39 | 0.040 |
Why?
|
| Lipocalins | 2 | 2010 | 34 | 0.040 |
Why?
|
| Acute-Phase Proteins | 2 | 2010 | 36 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2021 | 618 | 0.040 |
Why?
|
| Ammonia | 1 | 2019 | 45 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 153 | 0.040 |
Why?
|
| Urologists | 1 | 2019 | 34 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2015 | 4690 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 268 | 0.040 |
Why?
|
| Transcriptome | 1 | 2023 | 766 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2000 | 329 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2019 | 197 | 0.030 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 20 | 0.030 |
Why?
|
| Body Constitution | 1 | 1996 | 26 | 0.030 |
Why?
|
| Urothelium | 2 | 2007 | 69 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 647 | 0.030 |
Why?
|
| Transferrins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Reminder Systems | 1 | 2015 | 18 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 684 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1505 | 0.030 |
Why?
|
| Proteinuria | 1 | 2015 | 69 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2006 | 2603 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 150 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2015 | 193 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 246 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1994 | 119 | 0.030 |
Why?
|
| Osteocalcin | 1 | 1993 | 25 | 0.030 |
Why?
|
| Ligases | 1 | 1993 | 47 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2004 | 176 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 256 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 631 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1992 | 33 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 105 | 0.020 |
Why?
|
| Culture Media | 1 | 1992 | 149 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 266 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 3922 | 0.020 |
Why?
|
| Amino Acids | 1 | 1992 | 262 | 0.020 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2010 | 17 | 0.020 |
Why?
|
| Calculi | 1 | 2010 | 6 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 76 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 116 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 86 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 138 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 340 | 0.020 |
Why?
|
| Abdomen | 1 | 2010 | 124 | 0.020 |
Why?
|
| Adsorption | 1 | 1988 | 54 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2090 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2010 | 134 | 0.020 |
Why?
|
| Mathematics | 1 | 1988 | 191 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 83 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 454 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3040 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 799 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1988 | 380 | 0.020 |
Why?
|
| Video Recording | 1 | 2008 | 215 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 432 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 164 | 0.020 |
Why?
|
| Oxalic Acid | 1 | 1986 | 8 | 0.020 |
Why?
|
| Kinetics | 1 | 1988 | 1561 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1988 | 504 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 10307 | 0.010 |
Why?
|
| Living Donors | 1 | 2009 | 348 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 311 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1995 | 326 | 0.010 |
Why?
|
| Ileum | 1 | 2005 | 169 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 388 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 206 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 210 | 0.010 |
Why?
|
| Parathyroidectomy | 1 | 2004 | 79 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 235 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2003 | 27 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2005 | 721 | 0.010 |
Why?
|
| Titrimetry | 1 | 2001 | 15 | 0.010 |
Why?
|
| Particle Size | 1 | 2001 | 126 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2005 | 704 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1998 | 430 | 0.010 |
Why?
|
| Cyanides | 1 | 1995 | 16 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1995 | 95 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1995 | 130 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 297 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 297 | 0.010 |
Why?
|
| Protein Binding | 1 | 1998 | 1560 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1995 | 2088 | 0.000 |
Why?
|